Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)
CUSIP: 55234L105
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 1,644,695
- Total 13F shares
- 6,666,674
- Share change
- -312,776
- Total reported value
- $60,845,825
- Price per share
- $9.13
- Number of holders
- 33
- Value change
- -$2,645,260
- Number of buys
- 9
- Number of sells
- 23
Quarterly Holders Quick Answers
What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55234L105:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
196%
|
3,222,560
|
$25,877,000 | — | 30 Jun 2021 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
67%
|
1,100,852
|
$8,840,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
38%
|
624,684
|
$5,017,000 | — | 30 Jun 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
33%
|
542,644
|
$4,357,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
13%
|
220,029
|
$1,767,000 | — | 30 Jun 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
11%
|
183,076
|
$1,470,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
9.4%
|
155,135
|
$1,246,000 | — | 30 Jun 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
8.5%
|
139,187
|
$1,118,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
5.2%
|
85,327
|
$685,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
83,155
|
$668,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
4.6%
|
76,441
|
$614,000 | — | 30 Jun 2021 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
3.3%
|
55,000
|
$442,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.7%
|
44,000
|
$353,000 | — | 30 Jun 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
41,900
|
$336,000 | — | 30 Jun 2021 | |
| Tibra Equities Europe Ltd |
13F
|
Company |
2.4%
|
40,000
|
$321,000 | — | 30 Jun 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.4%
|
39,167
|
$314,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
36,102
|
$289,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
1.9%
|
31,539
|
$253,000 | — | 30 Jun 2021 | |
| Ergoteles LLC |
13F
|
Company |
1.9%
|
31,000
|
$249,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
30,987
|
$249,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
23,884
|
$192,000 | — | 30 Jun 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.4%
|
23,800
|
$191,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
21,529
|
$173,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
20,120
|
$161,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
19,381
|
$156,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.2%
|
19,321
|
$155,000 | — | 30 Jun 2021 | |
| Walleye Capital LLC |
13F
|
Company |
1.2%
|
19,093
|
$153,000 | — | 30 Jun 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
1.1%
|
18,602
|
$149,000 | — | 30 Jun 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.71%
|
11,610
|
$93,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
10,751
|
$86,000 | — | 30 Jun 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.27%
|
4,434
|
$36,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.08%
|
1,397
|
$11,000 | — | 30 Jun 2021 | |
| Cardinal Capital Management, Inc. |
13F
|
Company |
0.04%
|
650
|
$5,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
567
|
$5,000 | — | 30 Jun 2021 | |
| Laurel Wealth Advisors LLC |
13F
|
Company |
0.03%
|
500
|
$4,000 | — | 30 Jun 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
500
|
$4,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
500
|
$4,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
396
|
$3,000 | — | 30 Jun 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.01%
|
175
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q3 2021
As of 30 Sep 2021,
Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,666,674 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., PURA VIDA INVESTMENTS, LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, Soleus Capital Management, L.P., ArrowMark Colorado Holdings LLC, Parian Global Management LP, MILLENNIUM MANAGEMENT LLC, and BANK OF AMERICA CORP /DE/.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
38
Q3 2021 holders
33
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.